en · de · es · fr · pt
thymosin-alpha-1-notes.peptides4800.com › Guide › �ˆ†子身份与天然来源 — Background and Details

�ˆ†子身份与天然来源 — Background and Details

By Editorial Desk · published 2025-11-16 · last reviewed 2026-01-06 · Guide

acetylated peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2026-01-06. Numbers and descriptions here follow the published literature rather than marketing material.

分子身份与天然来源

20世纪70年代,研究者从胸腺提取物中纯化出多种小肽,Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤,产量低且成分复杂。随着固相肽合成技术成熟,实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上,并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

Research History and Clinical Assessment

Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Thymosin-alpha-1 at a glance

PropertyValueNotes
化学分类线性肽由28个氨基酸组成
分子量约3108 Da合成版本一致
外观白色至类白色粉末冻干品
溶解度易溶于水微溶于有机溶剂
储存温度-20°C(冻干)溶解后2-8°C

Background and Molecular Profile

Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.

The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.

The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.

Related pages on this site

Molecular Identity Of Thymosin Alpha-1

Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.

Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.

Molecular Background and Immune Action

Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.

Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.

Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.

Molecular Background and Identity

Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.

Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.

Supporting material

Briton Callum Tindal-Draper is killed while fighting with the 4th International Legion in Ukraine. 6 November – At Newcastle Crown Court, former GP Thomas Kwan is sentenced to 31 years in prison after posing as a community nurse to inject his mother's partner with a substance that caused him to contract a flesh eating disease following a row over inheritance. 7 November The Bank of England cuts the UK interest rate by 0.25% to 4.75%, but indicates further cuts may take longer than previously thought following the October budget, which it forecasts will lead to price increases. Argentinian authorities announce that three people have been charged in connection with the death of One Direction's Liam Payne. A report into more than 100 allegations of sexual abuse against barrister John Smyth QC, who died in 2018, finds his activities were covered up by the Church of England for several decades. Smyth used his home as a Christian summer camp during the 1970s and 1980s, when the abuse of boys and young men is thought to have happened. The Football Association opens a safeguarding inquiry into a Premiership club official following sexual allegations made by three women. The charity organisation Care England estimates that as a result of the increase in employers' National Insurance contributions and the national minimum wage in the recent budget, that the cost of providing care will increase by over £3,000 per person and that the increases are expected to be passed on to care home residents and their relatives.

Ioxaglic acid is an iodine-containing, water-soluble radiocontrast agent. The iodine atoms readily absorb X-rays, resulting in a higher contrast of X-ray images. It has a low osmolality of 600 mosm/kg water at 37 °C (99 °F), meaning that the solution has a relatively low concentration of molecules; this is usually associated with fewer adverse effects than high-osmolality contrast agents.

== Chemistry == Peptide analogues of oxytocin with similar actions, for example carbetocin (Duratocin) and demoxytocin (Sandopart), have been developed and marketed for medical use. In addition, small-molecule oxytocin receptor agonists, like TC OT 39, WAY-267464, and LIT-001 have been developed and studied. However, lack of selectivity over vasopressin receptors has so far limited the potential usefulness of small-molecule oxytocin receptor agonists.

Sources: en.wikipedia.org

Notes from published material

== Scientific investigations == Over the decades, many clinical studies have been performed to investigate TT's efficacy, as well as various meta-analyses and at least one systematic review, yielding varying results and conclusions. O'Mathúna et al., in discussing these studies, note several problems, such as failure to exclude methodologically flawed studies and a susceptibility to the publication bias of complementary medicine journals, which carry a "preponderance of studies with positive results"; they argue that

As a concession made by Lamartine to popular aspirations, and in exchange for the maintaining of the tricolor flag, he conceded the Republican triptych of Liberté, Égalité, Fraternité, written on the flag, on which a red rosette was also to be added. The first collision took place as to the form which the 1848 Revolution was to take. Lamartine wished for them to maintain their original principles, with the whole country as supreme, whereas the revolutionaries under Ledru-Rollin wished for the Republic of Paris to hold a monopoly on political power. On 5 March the government, under the pressure of the Parisian clubs, decided in favor of an immediate reference to the people, and direct universal suffrage, and adjourned it until 26 April. This added the uneducated masses to the electorate and led to the election of the Constituent Assembly on 4 May 1848. The provisional government having resigned, the republican and anti-socialist majority on 9 May entrusted the supreme power to an Executive Commission consisting of five members: Arago, Pierre Marie de Saint-Georges, Garnier-Pagès, Lamartine, and Ledru-Rollin. The result of the general election, the return of a predominantly moderate, if not monarchical, constituent assembly dashed the hopes of those who had looked for the establishment, by a peaceful revolution, of their ideal socialist state. but they were not prepared to yield without a struggle, and in Paris itself they commanded a formidable force.

Dorries eventually resigns on 26 August., 78 days after her initial announcement of "immediate effect". Boris Johnson's Resignation Honours are published. Highlights include knighthoods for Jacob Rees-Mogg and Simon Clarke, and a damehood for Priti Patel. The decision to award a life peerage to former special adviser Charlotte Owen is criticised due to her young age (29) and perceived lack of experience or contributions to British society. Johnson announces he will stand down as an MP with immediate effect after receiving the Commons Select Committee of Privileges's report into the Partygate scandal, triggering a by-election. 10 June Nigel Adams becomes the third Conservative MP in quick succession to stand down from Parliament with immediate effect, triggering a by-election. Temperatures reach above 30 °C for the first time since 24 August 2022, marking the hottest day of the year so far. Three guardsmen collapse during a military parade in London, due to the heat. Manchester City beat Inter Milan in the 2023 UEFA Champions League Final 1–0, with Rodri scoring the only goal to win the UEFA Champions League for the first time in their history. They become the second English team ever to win the Continental Treble after Manchester United in the 1998-99 Manchester United F.C. season, winning the FA Cup and the Premier League alongside the UEFA Champions League. 11 June Energy Secretary Grant Shapps, speaking on Sunday with Laura Kuenssberg, declares that the country "wants to move on" from Boris Johnson and dismisses claims the ex-PM was the victim of a "witch hunt".

Sources: en.wikipedia.org

Frequently asked questions

胸腺素α1是激素吗?

它不是经典的内分泌激素,而是一种免疫调节肽。其作用主要通过局部免疫细胞间的信号传递实现,而非经血液循环作用于远隔器官。

天然来源是什么?

天然胸腺素α1主要从胸腺组织提取,也可在脾脏和淋巴结中检出。目前研究和临床使用的多为化学合成版本,不再依赖动物组织。

它和胸腺素组分5有什么关系?

胸腺素组分5是牛胸腺提取物的粗组分,包含多种肽。胸腺素α1是其中一种被纯化和表征的单一肽,具有明确的28个氨基酸序列。

Why are clinical results inconsistent?

Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.

Network